Body weight loss (BWL) as aprognostic/predictive factor inpreviously treated patients (pts)with metastatic gastric orgastroesophageal junction cancer(mGC/GEJC): Post-hoc analyses of the phase III tags trial

Category Primary study
JournalJournal of Clinical Oncology
Year 2021
This article has no abstract
Epistemonikos ID: cfae403455dee71f0176618895be7ed8cb28ef4b
First added on: Feb 12, 2025